Excerpt from the April 2024 ICARE case conference featuring Dr. Ramaprasad Srinivasan from the National Cancer Institute discussing hereditary kidney cancer.
You can view the full ICARE Spring 2024 newsletter on the ICARE website at inheritedcancer.net/newsletters.
To view the details of the Bevacizumab, Erlotinib, and Atezolizumab in advanced-stage kidney cancer clinical trial, you may visit clinicaltrials.gov/study/NCT0...
Follow us to stay informed on your favorite social media platform:
LinkedIn: / inherited-cancer-registry
Twitter: / inheritedcancer
Instagram: / inheritedcancer
Facebook: / inheritedcancer
11 апр 2024